Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Quality of Life in the Multicenter, Randomized, Phase 3 GMMG-HD6 Trial Applying Elotuzumab, Lenalidomide, Bortezomib and Dexaemethason in Patients with Newly-Diagnosed Multiple Myeloma

Blood (2024) 144 (Supplement 1): 1963.

https://doi.org/10.1182/blood-2024-205230

Published: 2024

Journal Articles

Balancing Treatment Intervals and Quality of Life in Multiple Myeloma Patients: Patient Perspectives and Recommendations

Anna Fleischer, Mohammad Barakat, Sofie-Katrin Kadel, Julia Mersi, Johannes Waldschmidt, Hermann Einsele, K. Martin Kortüm, Imad Maatouk, Leo Rasche

Blood (2024) 144 (Supplement 1): 284.

https://doi.org/10.1182/blood-2024-205037

Published: 2024

Journal Articles

Taste Abnormalities Emerging during Anti-Myeloma Therapies Including GPRC5D x CD3 Bispecific Antibody Talquetamab

Anna Fleischer, Magdalena Roll, Franziska Panther, Goetz Gelbrich, Franziska Reinhardt, Christine Riedhammer, Julia Mersi, Johannes M Waldschmidt, Hermann Einsele, K. Martin Kortüm, Imad Maatouk, Leo Rasche

Blood (2023) 142 (Supplement 1): 2403.

https://doi.org/10.1182/blood-2023-186663

Published: 2023

Journal Articles

Is PFS the Right Endpoint to Assess Outcome of Maintenance Studies in Multiple Myeloma? Results of a Patient Survey Highlight Quality-of-Life As an Equally Important Outcome Measure

Anna Fleischer, Larissa Heimeshoff, Johannes Allgaier, Karin Jordan, Götz Gelbrich, Rüdiger Pryss, Johannes Schobel, Hermann Einsele, Martin Kortuem, Imad Maatouk, Niels Weinhold, Leo Rasche

Blood (2021) 138 (Supplement 1): 836.

https://doi.org/10.1182/blood-2021-152648

Published: 2021